{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:48:55Z","timestamp":1791946135317,"version":"4.3.4"},"reference-count":18,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc electrophysiol"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:p><jats:bold>Atrial Fibrosis and Sinus Node Dysfunction<\/jats:bold>.\u2002<jats:bold><jats:italic>Introduction:<\/jats:italic><\/jats:bold> Sinus node dysfunction (SND) commonly manifests with atrial arrhythmias alternating with sinus pauses and sinus bradycardia. The underlying process is thought to be because of atrial fibrosis. We assessed the value of atrial fibrosis, quantified using Late Gadolinium Enhanced\u2010MRI (LGE\u2010MRI), in predicting significant SND requiring pacemaker implant.<\/jats:p><jats:p><jats:bold>\n            <jats:italic>Methods:<\/jats:italic>\n          <\/jats:bold> Three hundred forty\u2010four patients with atrial fibrillation (AF) presenting for catheter ablation underwent LGE\u2010MRI. Left atrial (LA) fibrosis was quantified in all patients and right atrial (RA) fibrosis in 134 patients. All patients underwent catheter ablation with pulmonary vein isolation with posterior wall and septal debulking. Patients were followed prospectively for 329\u2003\u00b1\u2003245 days. Ambulatory monitoring was instituted every 3 months. Symptomatic pauses and bradycardia were treated with pacemaker implantation per published guidelines.<\/jats:p><jats:p><jats:bold>\n            <jats:italic>Results:<\/jats:italic>\n          <\/jats:bold> The average patient age was 65\u2003\u00b1\u200312 years. The average wall fibrosis was 16.7\u2003\u00b1\u200311.1% in the LA, and 5.3\u2003\u00b1\u20036.4% in the RA. RA fibrosis was correlated with LA fibrosis (R<jats:sup>2<\/jats:sup>= 0.26; P &lt; 0.01). Patients were divided into 4 stages of LA fibrosis (Utah I: &lt;5%, Utah II: 5\u201320%, Utah III: 20\u201335%, Utah IV: &gt;35%). Twenty\u2010two patients (mean atrial fibrosis, 23.9%) required pacemaker implantation during follow\u2010up. Univariate and multivariate analysis identified LA fibrosis stage (OR, 2.2) as a significant predictor for pacemaker implantation with an area under the curve of 0.704.<\/jats:p><jats:p><jats:bold>\n            <jats:italic>Conclusions:<\/jats:italic>\n          <\/jats:bold> In patients with AF presenting for catheter ablation, LGE\u2010MRI quantification of atrial fibrosis demonstrates preferential LA involvement. Significant atrial fibrosis is associated with clinically significant SND requiring pacemaker implantation. <jats:italic>(J Cardiovasc Electrophysiol, Vol. 23, pp. 44\u201050, January 2012)<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1540-8167.2011.02140.x","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T16:59:37Z","timestamp":1312217977000},"page":"44-50","source":"Crossref","is-referenced-by-count":128,"title":["Atrial Fibrosis Quantified Using Late Gadolinium Enhancement MRI is Associated With Sinus Node Dysfunction Requiring Pacemaker Implant"],"prefix":"10.1111","volume":"23","author":[{"given":"NAZEM","family":"AKOUM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHRISTOPHER","family":"MCGANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GASTON","family":"VERGARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TROY","family":"BADGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAVI","family":"RANJAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHRISTIAN","family":"MAHNKOPF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EUGENE","family":"KHOLMOVSKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROB","family":"MACLEOD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NASSIR","family":"MARROUCHE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"e350","article-title":"ACC\/AHA\/HRS 2008 guidelines for device\u2010based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (writing committee to revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): Developed in collaboration with the American Association for Thoracic Surgery and Society Of Thoracic Surgeons","volume":"117","author":"Writing Committee Members","year":"2008","journal-title":"Circulation"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2953"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.15.1807"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000090685.13169.07"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.098"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.40.12.1384"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.02.046"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.811877"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2010.01876.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2009.01611.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2007.04.005"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.9.3157"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00178-9"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00258-4"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809033391003"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1998.tb01836.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2007.00941.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/eupc.2000.0118"}],"container-title":["Journal of Cardiovascular Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8167.2011.02140.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8167.2011.02140.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T14:20:27Z","timestamp":1698675627000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8167.2011.02140.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.1540-8167.2011.02140.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8167.2011.02140.x","archive":["Portico"],"relation":{},"ISSN":["1045-3873","1540-8167"],"issn-type":[{"value":"1045-3873","type":"print"},{"value":"1540-8167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}